Q-omics provides the consensus-scored PGAM1P12 profile across patient tissues and cancer cell-line models. PGAM1P12 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in STAD. Among the 18 cancer types available for tumor–normal comparison, PGAM1P12 is differentially expressed in 4, with the highest sampling consensus in COAD. Additionally, PGAM1P12 RNA expression shows 7,026 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight STAD, COAD, and ACC as cancer lineages where PGAM1P12 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for PGAM1P12 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes PGAM1P12 survival associations across molecular data types. PGAM1P12 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible PGAM1P12 RNA expression–survival associations across cancer types. High PGAM1P12 expression shows unfavorable associations in STAD, ACC, MESO and BRCA, but favorable associations in KIRC and HNSC. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for PGAM1P12 RNA expression.
This table summarizes PGAM1P12 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for PGAM1P12. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. PGAM1P12 shows lower tumor expression in KIRC and THCA and higher tumor expression in COAD and LUSC. The COAD box plot shows higher PGAM1P12 RNA expression in tumor versus normal tissue (log2 FC = +0.049, t-test p = .044).
This table shows molecular features associated with PGAM1P12 in patient tissues and cancer cell lines. In patient samples, PGAM1P12 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
